바로가기 메뉴
본문 바로가기
주메뉴 바로가기
푸터 바로가기

Information on the Test Items

Providing Information on the Test Items.

Rapid drug susceptibility Testing

The rapid drug susceptibility testing is a method that swiftly confirms resistance to Isoniazid (INH) and Rifampicin (RIF). It involves amplifying genes associated with resistance using PCR, then reacting with oligonucleotide probes to detect genetic mutations through Line Probe Assay (LPA).

Method

Line probe assay

  • Rapid drug susceptibility Testing cell image
  • Rifampicin Resistance

    Detection of rpoB gene mutation

    Rapid drug susceptibility Testing cell image
    Isoniazid Resistance

    Detection of katG mutation, as well as inhA and ahpC gene mutations

    Rapid drug susceptibility Testing cell image
Insurance Code D604203A[RIF] / D604204A[INH]
Classification Number 누-604나
Turnaround Time Within 2 days
Requirement

Samples must be positive for culture or acid-fast bacilli (1+ or above)

Contact